Snowball logo
logo
6185

Cansino Biologics Inc.

6185 β€’ HK
HK$34.86-HK$1.68Β  (4.6%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
4,299.71,031313.9795.31,0321,226.5
COGS
1,296.51,217.61,110.5229.7350.2422.2
Gross Profit
3,003.2(186.6)(796.6)565.6681.8879.3
Operating Expenses & Income
Operating Income
1,940.8(1,368.7)(1,850.6)(352.6)(113.1)(56.71)
Total Operating Expenses
1,201.41,182.11,054901794.9898.1
R&D Expenses
878.7778.3580.1391230.5286.2
Selling General & Admin Expenses
231.8278.1267.7182.6173.1355.7
Earnings from Continuing Operations
Interest Expense
(20.42)(41.34)(58.33)(56.36)(55.81)(27.27)
Interest Income
79.65185.251.3721.0122.25.274
Income Tax Expense
29.7(219.2)(10.41)2.31815(5.976218)6.38729
Net Income
Net Income
1,914.4(909.4)(1,348.3)(356)27.1540.63
Supplemental
EBIT
1,784.1(1,499)(1,741.1)(352.6)(113.1)-
EBITDA
1,849.2(1,318.8)(1,496.4)(126.7)60.9838.17
In millions of HKD, except % and values per 1 share